Although
calcium phosphate cements (CPCs) have been clinically used to repair bone defects caused by bone
tumor resection, traditional CPCs cannot kill the remaining
tumor cells after surgery and prevent
cancer recurrence. In this study, a multifunctional
injectable metal-organic framework (MOF)
cobalt coordinated tetrakis(4-carboxyphenyl)porphyrin (Co-
TCPP)-modified
calcium phosphate cement (Co-
TCPP/
CPC) was prepared for the minimally invasive treatment of neoplastic bone defects. The incorporation of Co-
TCPP not only retained the good injectability of
bone cements, but also shortened the setting time, improved the compressive strength, and endowed them with excellent photothermal properties. The
hyperthermia effect induced by the presence of Co-
TCPP well induced the
therapeutic effect against bone
tumors both in vitro and in vivo. Moreover, Co-
TCPP/
CPC exhibited desirable osteogenesis and angiogenesis by promoting bone and vascular regeneration in vivo. Therefore, the Co-
TCPP composite
bone cement demonstrated its great potential for bone
tumor therapy and tissue regeneration, representing a multifunctional
biomaterial for the treatment of neoplastic bone defects.